Sudden cardiac death is a feared complication of hypertrophic cardiomyopathy (HCM). Therapies to reduce the incidence of sudden cardiac death have included implantable defibrillators and surgical- and catheter-based approaches to reduce obstruction by septal reduction.
Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
Heart failure due to diastolic dysfunction is common in hypertensive patients, yet little is known about the effect of antihypertensive agents on diastolic dysfunction.
Carotid-artery stenting (CAS) has evolved significantly over recent years to become a reasonable alternative to carotid endarterectomy (CEA) for selected patients with carotid-artery disease.
The presence of cerebral complications of infective endocarditis (IE) can affect diagnostic and treatment decisions. Thus, this group from Paris, France, evaluated whether early cerebral MRI would affect the diagnosis and management of hospitalized patients suspected of having IE.
Being overweight or obese increases the risk of cirrhosis. In this study, excess body weight contributed to almost 20% of the cirrhosis-related hospital admissions and deaths, while alcohol contributed to almost 50%.
Contrary to the current guidelines, in the long term, an average of approximately 60 min/day of moderate-intensity activity for women is required to be successful in maintaining a normal weight.
The FDA has approved a miconazole buccal tablet for the treatment of oropharyngeal candidiasis. This once-daily mucoadhesive buccal tablet provides slow release of the drug over the course of the day. The tablet is marketed by Strativa Pharmaceuticals as Oravig™.
